pharma · Hematologic Malignancies · Solid Tumor, Adult
Farmatek
Zafatek
Farmatek trial registry — 26 ClinicalTrials.gov studies with program phase, status, and indication context.
Aydınlı - KOSB Mah. Tuzla Kimya Sanayicileri Org. San. Böl. Analitik Cad. No:90 Tuzla, Istanbul, TR, JP HQ
1994 Founded
14 Employees
PMDA registrant Type
Company details
- Status
- Public
- HQ
- Aydınlı - KOSB Mah. Tuzla Kimya Sanayicileri Org. San. Böl. Analitik Cad. No:90 Tuzla, Istanbul, TR, JP
- Founded
- 1994
- Employees
- 14
- Programs
- 26
- Drugs
- 14
- Patents
- 53
Farmatek clinical trials
Registry index of 26 ClinicalTrials.gov studies linked to Farmatek programs — each row shows trial ID, program name, phase, status, and indication.
Farmatek trial registry — 26 ClinicalTrials.gov studies with program phase, status, and indication context.
Recent trial activity
Latest clinical program signals indexed for Farmatek.
-
MINOCIN 100 mg capsule rigide — Phase 2
Clinical update -
FT819 — Phase 1
Clinical update -
FT576 (Allogenic CAR NK cells with BCMA expression) — Phase 1
Clinical update -
Fludarabine — Phase 1
Clinical update -
Biological: ProHema-CB — Phase 1
Clinical update -
Single FT1050 treated UCB unit — Phase 1
Clinical update -
ESTECLIN 300 MG CAPSULE RIGIDE — Approved
Clinical update -
ProTmune — Phase 2
Clinical update